ILMN - Illumina Inc
Illumina Inc Logo

ILMN - Illumina Inc

https://www.illumina.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.

52W High
$156.66
52W Low
$68.70
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.43
Valuation
Fair
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
12.52
Forward P/E (<15 better)
19.96
EV/EBITDA (<8 favorable)
9.59
EV/Revenue (<3 favorable)
3.99
P/S (TTM) (<3 favorable)
3.66
P/B (<3 favorable)
6.94
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.19%
Institutions (25–75% balanced)
103.37%
Shares Outstanding
158,300,000
Float
149,347,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
4,284,000,000
Gross Profit (TTM)
2,920,000,000
EPS (TTM)
7.90
Profit Margin (>10% good)
0.29%
Operating Margin (TTM) (higher better)
0.21%
ROE (TTM) (>15% strong)
0.68%
EPS YoY (Quarterly) (>10% good)
-0.97
Revenue YoY (Quarterly) (>8% good)
-0.05
Momentum
Bearish momentum
Value
-0.7194
Previous
-0.4195
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025